PLAT and stroke disorder: However, the management of acute ischemic stroke has not made significant strides since the introduction of recombinant tissue plasminogen activator (r-TPA) two decades ago [3], and r-TPA is the only thrombolytic agent approved by the US Food and Drug Administration for stroke treatment [6].